Search

everythinglearnresearchcommunity

for

Search:↓

A study found that minoxidil can damage the hearts of dogs and pigs, cautioning its use in humans.

The document compares oral-maxillofacial surgery training in Thailand, France, and Germany, highlighting differences in curriculum focus and medical rotations.

An adult with Kawasaki disease experienced temporary heart failure but recovered without lasting heart damage.

Trastuzumab deruxtecan is effective for HER2-positive breast cancer but requires careful management of side effects.

Cancer treatments targeting specific cells often cause skin, hair, and nail problems, affecting patients' lives and requiring careful management.

The document concludes that patient outcomes for Congenital Adrenal Hyperplasia are often not ideal because of poor management and a need for better diagnosis and treatment methods.

In 2002, various drugs caused serious side effects, including vitamin B12 deficiency, heart issues, blindness, hypersexuality, allergic reactions, blood clotting problems, pupil dilation, capillary leak syndrome, muscle breakdown, hepatitis, skin reactions, and lupus.

Cepharanthine, a Japanese hair loss drug, shows promise as a COVID-19 treatment but needs more testing.

Bendamustine, often combined with other drugs, is effective and less toxic for certain blood cancers, but less effective for young, fit patients with CLL.

Psychotropic medications can cause skin reactions, including severe conditions like SJS and TEN, and it's important for psychiatrists to recognize and manage these side effects.

Netherton syndrome can cause severe and chronic vulvovaginal symptoms that may improve with continuous oral contraceptives.

Hair transplantation is a surgical procedure to move hair to bald areas, requires good donor hair, and results show in about a year.

Melatonin receptors, found in many body parts, can help treat various diseases like depression and diabetes due to their effects on inflammation, tumor progression, sleep disorders, and body mass regulation.

The Blood Glucose Management Service improved patient safety and outcomes in managing blood sugar in hospitalized patients.

PEGylated liposomal doxorubicin improves cancer treatment effectiveness and reduces side effects like heart damage and hair loss.

PCOS is a common hormonal disorder in women, often involving menstrual issues and increased diabetes risk, managed through lifestyle changes and targeted treatments.

A dog's chronic bite wound healed successfully using a mix of herbal gel, low power laser, and ozone therapy.

Cortexolone 17a-propionate may be an effective new treatment for hair loss.

Non-ablative and ablative fractional lasers helped hair growth in some cases without major side effects, but didn't work for all hair disorders.

A woman with a rare scalp lymphoma had unusual hair loss after treatment.

Immunosuppressive and anti-TNF therapies in IBD patients can increase the risk of skin cancer and cause various skin issues.

The update highlights that non-classic congenital adrenal hyperplasia is common in women with excess male hormones, requires specific hormone tests for diagnosis, and has various treatment options depending on age and symptoms.

Sorafenib is effective in treating Desmoid Tumor/Deep Fibromatosis.

Alopecia Areata has no guaranteed treatment for hair regrowth, but options like corticosteroids and minoxidil are used, with future research focusing on genetic and immune therapies.

PEGL-DOX causes Hand-Foot Syndrome due to skin reactions from prolonged circulation and ROS generation.

The nanoparticle-emulsion with polihexanide is more effective and lasts longer for skin antisepsis.

Recombinant thrombomodulin can effectively treat severe complications in Cronkhite-Canada syndrome.

Cancer treatments can cause skin-related side effects that may affect patient quality of life and require changes in treatment.

Certain hormone treatments can improve acne and related conditions in women.

As of 1994, treatments for liver cancer had not significantly improved patient survival.